TGFB1 and cancer: By simultaneously activating the NF-κB and TGF-β/Smad pathways and weakening NK cell function, platelet-derived TGF-β and direct interactions between platelets and tumor cells can trigger a mesenchymal-like transition and facilitate metastasis in cancer cells [38, 39].